Company Urovant Sciences Ltd.
Equities
UROV
BMG9381B1081
Biotechnology & Medical Research
Business Summary
Number of employees: 70
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 19-02-28 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 19-10-27 |
Chief Tech/Sci/R&D Officer | 66 | - | |
Ryan Kubota
IRC | Investor Relations Contact | - | - |
Kenton Stewart
SAM | Sales & Marketing | - | 20-06-01 |
Nori Ebersole
HRO | Human Resources Officer | 60 | 17-11-30 |
Walt Johnston
PRN | Corporate Officer/Principal | - | 20-06-01 |
Christine Ocampo
AUD | Comptroller/Controller/Auditor | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20-05-19 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 18-06-30 |
James Robinson
CEO | Chief Executive Officer | 54 | 19-02-28 |
Director/Board Member | 59 | 19-12-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,743,396 | 5,633,501 ( 17.20 %) | 0 | 17.20 % |
Company contact information
Urovant Sciences Ltd.
11-12 Saint James's Square Suite 1
SW1Y 4LB, London
+
Sector
1st Jan change | Capi. | |
---|---|---|
-3.02% | 102B | |
+1.55% | 96.09B | |
+2.13% | 22.28B | |
-17.15% | 21.4B | |
-8.98% | 18.14B | |
-39.98% | 17.02B | |
-14.29% | 16.09B | |
+7.73% | 13.83B | |
+33.02% | 11.97B |